One of the researchers described the circumstances that led to the discovery as “serendipity.” This year’s prestigious Lasker ...

Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Glucagon-like peptide 1 (GLP-1) receptor agonists like semaglutide (Ozempic, ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Natural supplements have “very mild effects” on weight loss based on what Dr. Ali has seen. There is some data to suggest ...

Mazdutide is a dual glucagon-like peptide-1 receptor (GLP-1R)/glucagon receptor (GCGR) agonist. Targeting glucagon receptor ...

For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 ...

Three scientists are honoured for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

It seems like a day doesn’t go by without another positive finding for the glucagon-like peptide 1 (GLP-1) receptoragonist ...

As Novo Nordisk A/S and Eli Lilly and Co. go head-to-head in the U.S. and Chinese glucagon-like peptide-1 receptor agonists (GLP-1RA) market for diabetes and obesity, Novo Nordisk is in innovator gear ...

The overall findings from the landmark FLOW trial confirmed the potential of glucagon-like peptide 1 (GLP-1) receptor ...

As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of. As ...